CA19-9

There are 30 papers on CA19-9 in aging research: 1 trial and 24 observational studies in people, 4 reviews.

Biomarker

30 papers study it13 more mention it8 findings

9 new papers in 30 daysSee all 43 papers on CA19-9

“with CA19-9 achieving the highest overall performance of 0.94 (95% CI: 0.86-1.00).”
Assessment of impending pancreatic cancer in a cohort of new onset diabetes on basis of biomarker trajectorymedRxiv : the preprint server for health sciences2026doi:10.64898/2026.08.06.26359908
  • Human trial1
  • Humans24

Effects

1

PDAC risk factor count

no changein humans1

1 study
  1. CA19-9 was not clearly linked with PDAC risk factor count in humans.

    “No difference between normal and abnormal results were observed for CA19-9.”

    Humansn = 265

    Association of Apolipoprotein A2 Isoform Index with Demographic, Behavioral, and Clinical Risk Factors for Pancreatic Ductal Adenocarcinoma in a Single-Center Observational Study: Prelude to a Pancreatic Cancer Screening Algorithm?

    Preprints.orgPreprint

More on PDAC risk factor count

Upstream

1

Skeletal muscle and adipose tissue loss

no changein humans1

1 study
  1. Skeletal muscle and adipose tissue loss was not clearly linked with CA19-9 in pancreatic cancer cases.

    “are not correlated with at-diagnosis circulating levels of CA19-9”

    Humansin pancreatic cancer casesblood

    Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer

    Nature communications

Associations

6

Concomitant pancreatic ductal adenocarcinoma

upin humans1

1 study
  1. CA19-9 predicts concomitant pancreatic ductal adenocarcinoma in humans.

    “CA19-9 elevation and new or worsening diabetes predicted cPDAC.”

    HumansPatients with branch-duct intraductal papillary mucinous neoplasm without baseline worrisome features or high-risk stigmataUp to 5.17 years

    Prospective Evidence of Concomitant Pancreatic Ductal Adenocarcinoma Risk Among Patients With Branch-duct Intraductal Papillary Mucinous Neoplasms Without Worrisome Features/High-risk Stigmata at Baseline

    Annals of surgery

More on Concomitant pancreatic ductal adenocarcinoma

PDAC diagnosis

upin humans1

1 study
  1. CA19-9 predicts PDAC diagnosis in humans (patients with benign pancreatic diseases) (AUC 0.96 vs. 0.87, P = 0.003).

    “significant differences at 0-3 months (0.96 vs. 0.87, P = 0.003)”

    Humanspatients with benign pancreatic diseasesserum0-3 months before diagnosis

    Utility of longitudinal changes in CA19-9 for detection of pancreatic ductal adenocarcinoma in patients with benign pancreatic diseases

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Early detection of PDAC

upin humans1

1 study
  1. CA19-9 predicts early detection of PDAC in humans (patients with benign pancreatic diseases) (AUC 0.69 vs. 0.56, P = 0.004).

    “From 12 to 18 months before diagnosis, the logistic regression model demonstrated higher AUC values than the conventional cutoff of 37 U/mL”

    Humanspatients with benign pancreatic diseasesserum12-18 months before diagnosis

    Utility of longitudinal changes in CA19-9 for detection of pancreatic ductal adenocarcinoma in patients with benign pancreatic diseases

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Pancreatic cancer

upin humans1

1 study
  1. CA19-9 predicts pancreatic cancer in humans (new-onset diabetes; PDAC versus non-cancer controls) (AUC 0.94 (95% CI 0.86–1.00); sensitivity 83.3% at 97.2% specificity).

    “with CA19-9 achieving the highest overall performance of 0.94 (95% CI: 0.86-1.00).”

    Humansnew-onset diabetes; PDAC versus non-cancer controlsplasma3 yearsn = 2,121

    Assessment of impending pancreatic cancer in a cohort of new onset diabetes on basis of biomarker trajectory

    medRxiv : the preprint server for health sciencesPreprint

More on Pancreatic cancer

Colorectal polyp

mixedin humans1

1 study
  1. CA19-9 predicts colorectal polyp in humans (Feature importance analysis) (Top predictive factor).

    “Feature importance analysis revealed CA19-9 as the top predictive factor.”

    HumansFeature importance analysisn = 946

    An ensemble machine learning approach for predicting colorectal polyps using novel inflammatory markers

    BMC gastroenterology

More on Colorectal polyp

Pancreatic ductal adenocarcinoma

upin humans1

1 study
  1. CA19-9 predicts pancreatic ductal adenocarcinoma in humans (PDAC vs controls) (AUC 91.7 [95% CI, 87.8-95.6]).

    “the AUC for serum CA19-9 alone was 91.7 [95% confidence interval (CI), 87.8-95.6]”

    HumansPDAC vs controls

    Blood test panel better distinguished pancreatic cancer cases

    Clinical cancer research : an official journal of the American Association for Cancer Research

More on Pancreatic ductal adenocarcinoma

Latest

Dec 2025: 1Jan 2026: 2Feb 2026: 3Mar 2026: 7Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 4Sep 2026: 4Oct 2026: 8Nov 2026: 434 papers in 12 months

See all 43 papers on CA19-9